Literature DB >> 21571963

B-cell lymphoma with hyaline vascular Castleman disease-like features: a clinicopathologic study.

Imran N Siddiqi1, Russell K Brynes, Endi Wang.   

Abstract

Hyaline vascular Castleman disease (HV-CD) is a localized benign mass characterized by follicular hyperplasia with atrophic germinal centers, mantle zone hyperplasia, hyaline deposits, and vascular proliferation. Before establishing a diagnosis of CD, several B-cell lymphomas (BCLs) must be considered, including follicular lymphoma (FL), mantle cell lymphoma (MCL), and nodal marginal zone lymphoma (NMZL). Conversely, BCLs with prominent atrophic germinal centers and hyaline vascular penetration may closely resemble HV-CD, leading to misdiagnosis. We report 6 cases of BCL with prominent HV-CD-like features, including FL (2 cases), MCL, NMZL (2 cases), and interfollicular large B-cell lymphoma. Histologically, all were initially considered to be HV-CD before additional tests revealed a neoplastic B-cell proliferation. We highlight the clinicopathologic features of these cases in comparison with cases diagnostic of HV-CD. In contrast with HV-CD, BCLs with HV-CD-like features are more likely to manifest clinically with systemic symptoms or generalized lymphadenopathy. Careful histopathologic examination, supported with immunohistochemical studies, flow cytometric immunophenotyping, and judicious use of cytogenetic and molecular analyses, allows identification of the masked neoplastic process. A multifaceted approach, integrating clinical, histologic, and ancillary tests, can help avoid this diagnostic pitfall.

Entities:  

Mesh:

Year:  2011        PMID: 21571963     DOI: 10.1309/AJCPF5AESY7OWIXF

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.

Authors:  Michiel van den Brand; J Han J M van Krieken
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

Review 2.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

3.  Morphologic variant of follicular lymphoma reminiscent of hyaline-vascular Castleman disease.

Authors:  Jiwon Koh; Yoon Kyung Jeon
Journal:  J Pathol Transl Med       Date:  2020-02-05

Review 4.  Primary hyaline vascular Castleman disease of the kidney: case report and literature review.

Authors:  Yunzhu Li; Haixia Zhao; Bingyin Su; Chan Yang; Shurong Li; Wanlei Fu
Journal:  Diagn Pathol       Date:  2019-08-22       Impact factor: 2.644

5.  Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like features.

Authors:  Kazuto Togitani; Mitsuko Iguchi; Tadashi Asagiri; Fumiya Ogasawara; Ichiro Murakami; Kensuke Kojima
Journal:  J Clin Exp Hematop       Date:  2021-10-26

6.  A case report of syndrome of inappropriate antidiuretic hormone secretion with Castleman's disease and lymphoma.

Authors:  Chong-Gui Zhu; Qiu-Zi Zhang; Mei Zhu; Qiong-Li Zhai; Xiao-Yu Liang; Zong-Hong Shao; Emily C Ver Hoeve; Hui-Qi Qu
Journal:  BMC Endocr Disord       Date:  2013-06-04       Impact factor: 2.763

7.  Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease.

Authors:  Kohei Shiroshita; Taku Kikuchi; Mikio Okayama; Hidenori Kasahara; Takahiro Kamiya; Takayuki Shimizu; Nozomu Kurose; Yasufumi Masaki; Shinichiro Okamoto
Journal:  Intern Med       Date:  2020-08-04       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.